Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Diabetes Care|May 1, 1995
Trends in cigarette smoking and physicians' advice to quit smoking among people with diabetes in the U.SA M Malarcher, E S Ford, D E Nelson, et al.Diabetes Care|December 5, 1998
Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work GroupM M Engelgau, L S Geiss, D L Manninen, et al.The Journal of Pediatrics|May 10, 2000
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspectiveA Fagot-Campagna, D J Pettitt, M M Engelgau, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.Diabetes Care|February 1, 1993
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy ProgramM B Willhoite, H W Bennert, G E Palomaki, et al.Annals of Internal Medicine|October 24, 1998
Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trialR E Aubert, W H Herman, J Waters, et al.Journal of Gerontology|November 1, 1993
Aging and insulin sensitivity: role of blood pressure and sympathetic nervous system activityM A Supiano, R V Hogikyan, L A Morrow, et al.The American Journal of Physiology|November 1, 1992
Hypertension and insulin resistance: role of sympathetic nervous system activityM A Supiano, R V Hogikyan, L A Morrow, et al.Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.Diabetes|January 1, 1994
Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigreeW H Herman, S S Fajans, F J Ortiz, et al.Pageof 12